Citations Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

Olagunju, Andrew T., Scott R. Clark, and Bernhard T. Baune. "Clozapine and psychosocial function in schizophrenia: a systematic review and meta-analysis." CNS drugs 32, no. 11 (2018): 1011-1023.

Wolff, Amy R., Alexei M. Bygrave, David J. Sanderson, Edward S. Boyden, David M. Bannerman, Dimitri M. Kullmann, and Dennis Kätzel. "Optogenetic induction of the schizophrenia-related endophenotype of ventral hippocampal hyperactivity causes rodent correlates of positive and cognitive symptoms." Scientific reports 8, no. 1 (2018): 1-12.

Keilhoff, Gerburg, Paolo Fusar-Poli, and Axel Becker. "Effects of antipsychotics on dentate gyrus stem cell proliferation and survival in animal models: a critical update." Neural plasticity 2012 (2012).

Janetsian-Fritz, Sarine S., Nicholas M. Timme, Maureen M. Timm, Aqilah M. McCane, Anthony J. Baucum II, Brian F. O’Donnell, and Christopher C. Lapish. "Maternal deprivation induces alterations in cognitive and cortical function in adulthood." Translational psychiatry 8, no. 1 (2018): 1-15.

Stuchlik, A., S. Kubik, K. Vlcek, and K. Vales. "Spatial navigation: implications for animal models, drug development and human studies." Physiological research 63 (2014).

Oliver, Peter L. "Challenges of analysing gene-environment interactions in mouse models of schizophrenia." TheScientificWorldJOURNAL 11 (2011): 1411-1420.

Xu, Meng-yi, and Albert HC Wong. "GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia." Acta Pharmacologica Sinica 39, no. 5 (2018): 733-753.

Roes, Meighen M., John Yin, Laura Taylor, Paul D. Metzak, Katie M. Lavigne, Abhijit Chinchani, Christine M. Tipper, and Todd S. Woodward. "Hallucination-Specific structure-function associations in schizophrenia." Psychiatry Research: Neuroimaging 305 (2020): 111171.

Wilson, Christina A., Rosanne Schade, and Alvin V. Terry Jr. "Variable prenatal stress results in impairments of sustained attention and inhibitory response control in a 5-choice serial reaction time task in rats." Neuroscience 218 (2012): 126-137.

Samson, James N., and Albert HC Wong. "The genetics of schizophrenia." (2015): 1-27.

Kapila, Adisha, Helen L. Fisher, Sonia Johnson, Barnaby Major, Nikola Rahaman, John Joyce, Nick Chamberlain?Kent, Jo Lawrence, Allan H. Young, and James M. Stone. "Clinical and demographic differences between patients with manic, depressive and schizophrenia?spectrum psychoses presenting to Early Intervention Services in London." Early intervention in psychiatry 13, no. 3 (2019): 509-516.

Fakhoury, Marc. "Could cannabidiol be used as an alternative to antipsychotics?." Journal of psychiatric research 80 (2016): 14-21.

Lang, XiaoE, Xin Hou, Fangfang Shangguan, and Xiang Yang Zhang. "Prevalence and clinical correlates of subclinical hypothyroidism in first-episode drug-naive patients with major depressive disorder in a large sample of Chinese." Journal of affective disorders 263 (2020): 507-515.

Redrobe, John P., Morten Jørgensen, Claus T. Christoffersen, Liliana P. Montezinho, Jesper F. Bastlund, Martin Carnerup, Christoffer Bundgaard, Linda Lerdrup, and Niels Plath. "In vitro and in vivo characterisation of Lu AF64280, a novel, brain penetrant phosphodiesterase (PDE) 2A inhibitor: potential relevance to cognitive deficits in schizophrenia." Psychopharmacology 231, no. 16 (2014): 3151-3167.

Reniers, Renate LEP, Belinda Garner, Christina Phassouliotis, Lisa J. Phillips, Connie Markulev, Christos Pantelis, Sarah Bendall, Patrick D. McGorry, and Stephen J. Wood. "The relationship between stress, HPA axis functioning and brain structure in first episode psychosis over the first 12 weeks of treatment." Psychiatry Research: Neuroimaging 231, no. 2 (2015): 111-119.

Morris, Sarah E., Uma Vaidyanathan, and Bruce N. Cuthbert. "Changing the diagnostic concept of schizophrenia: the NIMH research domain criteria initiative." In The Neuropsychopathology of Schizophrenia, pp. 225-252. Springer, Cham, 2016.

Trzesniak, Clarissa, Matthew J. Kempton, Geraldo F. Busatto, Irismar Reis de Oliveira, Amanda Galvão-de Almeida, Joseph Kambeitz, Maria Cecília Freitas Ferrari et al. "Adhesio interthalamica alterations in schizophrenia spectrum disorders: a systematic review and meta-analysis." Progress in Neuro-Psychopharmacology and Biological Psychiatry 35, no. 4 (2011): 877-886.

Winship, Ian R., Serdar M. Dursun, Glen B. Baker, Priscila A. Balista, Ludmyla Kandratavicius, Joao Paulo Maia-de-Oliveira, Jaime Hallak, and John G. Howland. "An overview of animal models related to schizophrenia." The Canadian Journal of Psychiatry 64, no. 1 (2019): 5-17.

Steinau, Sarah, Katharina Stegmayer, Fabian U. Lang, Markus Jäger, Werner Strik, and Sebastian Walther. "Comparison of psychopathological dimensions between major depressive disorder and schizophrenia spectrum disorders focusing on language, affectivity and motor behavior." Psychiatry research 250 (2017): 169-176.

Redrobe, John P., Sascha Bull, and Niels Plath. "Translational aspects of the novel object recognition task in rats abstinent following sub-chronic treatment with phencyclidine (PCP): effects of modafinil and relevance to cognitive deficits in schizophrenia." Frontiers in psychiatry 1 (2010): 146.